What Changed on February 5, 2026 On February 5, 2026, multiple outlets reported that Hims & Hers said it is launching a compounded semaglutide pill option and that Novo Nordisk responded by criticizing the move and signaling potential legal action
[ Break ] Michael Calore: I want to shift gears a bit and talk about what we're learning from the trials and the research being done on GLP-1 drugs
Using them is essentially being a guinea pig for compounds that haven't been properly tested
For researchers interested in newer alternatives, articles covering survodutide versus tirzepatide , CagriSema versus tirzepatide , and orforglipron versus tirzepatide explore the next generation of GLP-1 medications
With our comprehensive approach, you can look forward to a healthier, more vibrant life
Is it possible to shed pounds with semaglutide and tirzepatide in San Diego